CARBON X-RAY · PHARMACEUTICALS

Akums Drugs and Pharmaceuticals: carbon disclosure.

What Akums Drugs and Pharmaceuticals published, drawn only from its own SEBI BRSR and XBRL filings.

69Carbon X-Ray score out of 100
StrongDisclosure band
#27Rank among 1,246 Indian filers
Ticker: AKUMS (NSE)Revenue: ₹4,359 cr (FY2025-26)Latest BRSR: FY2025-26
Summary

Akums Drugs and Pharmaceuticals disclosed Scope 1 emissions of 17,925 tCO2e and Scope 2 emissions of 120,256 tCO2e in its FY2025-26 BRSR filing. It published a Scope 3 figure of 116,735 tCO2e, reported as a single total without a category breakdown. Its BRSR Core attributes carry reasonable assurance, provided by BDO India Services Private Limited.

AS FILED

The disclosure record.

Every row is taken from the company's own filings. Where a row says not published, it means no figure was found in the filings reviewed, which is not the same as the company having no such figure.

DisclosureAs filed
Scope 117,925 tCO2e
Scope 2120,256 tCO2e
Scope 3116,735 tCO2e
Scope 3 by categoryNot published in the filings reviewed
BRSR Core assuranceReasonable assurance confirmed (BDO India Services Private Limited)
SBTiNot published in the filings reviewed
CDPNot published in the filings reviewed
Net-zero target year2050
Renewable electricity34%
Methodology documentedYes
SECTOR CONTEXT

How Pharmaceuticals discloses.

8companies in this sector in the index
87.5%publish a Scope 3 figure
62.5%carry confirmed BRSR Core assurance

Across all 1,246 Indian BRSR filers, 65.2% publish a Scope 3 figure and 43.4% carry confirmed reasonable assurance. Full method and figures in The State of Carbon Disclosure in India.

WHAT IT MEANS

Where the pressure lands next.

Based on the filings reviewed, the items not yet published are Scope 3 split by GHG Protocol category. Reasonable assurance on BRSR Core reaches the top 1,000 listed entities in FY 2026-27, and an assurer works back from each reported figure to the document behind it.

Is this your company? Run the full diagnostic, free.

Run a Carbon X-Ray →
FAQS

Common questions.

Does Akums Drugs and Pharmaceuticals disclose Scope 3 emissions?

Yes. Akums Drugs and Pharmaceuticals published a Scope 3 figure of 116,735 tCO2e, as a single total without a category breakdown.

Are Akums Drugs and Pharmaceuticals's carbon numbers assured?

Yes. Its BRSR Core attributes carry reasonable assurance, provided by BDO India Services Private Limited. Reasonable assurance is the higher of the two assurance levels and requires substantive testing back to source documents.

Where does this data come from?

SEBI BRSR and XBRL filings, BRSR Core assurance statements, the SBTi target dashboard and the CDP registry. Only figures the company itself published are attributed to it. Data as at 2026-09-25. Corrections to growth@climes.io.

Source: Akums Drugs and Pharmaceuticals FY2025-26 BRSR and XBRL filings, plus the SBTi and CDP registries. Compiled by Climes. This page reports what the company published and does not assess the accuracy of those figures.